Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats

International Journal of Cardiology

Volumn 172, Issue 2, 2014, Pages 530-532

  Sharma, Arun Kumar ^a   Khanna, Deepa ^a   Balakumar, Pitchai ^b  

^a Rajendra Institute of Technology and Sciences   (India)

^b AIMST UNIVERSITY   (Malaysia)

Author keywords

Diabetes mellitus; eNOS; Low dose dipyridamole; Nephropathy; PI3 K; Vascular endothelial dysfunction

Indexed keywords

CREATININE; DIPYRIDAMOLE; N(G) NITROARGININE METHYL ESTER; UREA; ANTITHROMBOCYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; KIDNEY DISEASE; LETTER; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASCULAR RING; ANIMAL; DIABETES MELLITUS; DRUG EFFECTS; KIDNEY; PATHOLOGY; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; DIABETES MELLITUS; DIPYRIDAMOLE; ENDOTHELIUM, VASCULAR; FEMALE; KIDNEY; MALE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 84900592887     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.01.053     Document Type: Article

References (6)

1. H.H. Kim, and J.K. Liao Translational therapeutics of dipyridamole Arterioscler Thromb Vasc Biol 28 2008 39 42
2. P.K. Venkatesh, C.B. Pattillo, and B. Branch et al. Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway Cardiovasc Res 85 2010 661 670
3. P. Balakumar, V.A. Chakkarwar, and M. Singh Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat Mol Cell Biochem 320 2009 149 162
4. P. Balakumar, V.A. Chakkarwar, P. Krishan, and M. Singh Vascular endothelial dysfunction: a tug of war in diabetic nephropathy? Biomed Pharmacother 63 2009 171 179
5. P. Khajehdehi, J. Roozbeh, and H. Mostafavi A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy Scand J Urol Nephrol 36 2002 145 148
6. Y. Ye, Y. Lin, and R. Perez-Polo et al. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination Am J Physiol Heart Circ Physiol 293 2007 813 818